Compounds > neptunium
Page last updated: 2024-08-22

neptunium and n,n',n'',n'''-tetra(1,2-dihydro-1-hydroxy-2-oxopyridine-6-carbonyl)-1,5,10,14-tetraazatetradecane

neptunium has been researched along with n,n',n'',n'''-tetra(1,2-dihydro-1-hydroxy-2-oxopyridine-6-carbonyl)-1,5,10,14-tetraazatetradecane in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ansoborlo, E; Durbin, PW; Hengé-Napoli, MH; Houpert, P; Montègue, B; Paquet, F; Raymond, KN1

Other Studies

1 other study(ies) available for neptunium and n,n',n'',n'''-tetra(1,2-dihydro-1-hydroxy-2-oxopyridine-6-carbonyl)-1,5,10,14-tetraazatetradecane

ArticleYear
Efficacy of 3,4,3-LIHOPO for reducing neptunium retention in the rat after simulated wound contamination.
    International journal of radiation biology, 2000, Volume: 76, Issue:1

    Topics: Animals; Aza Compounds; Bone and Bones; Chelating Agents; Female; Injections, Intramuscular; Kidney; Liver; Male; Neptunium; Pyridones; Rats; Rats, Sprague-Dawley; Time Factors

2000